{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:17:40Z","timestamp":1720689460627},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.3816\/clm.2008.s.013","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T02:03:23Z","timestamp":1229393003000},"page":"S168-S179","source":"Crossref","is-referenced-by-count":8,"special_numbering":"S5","title":["Pathobiology of Mature T-Cell Lymphomas"],"prefix":"10.3816","volume":"8","author":[{"given":"Claudiu V.","family":"Cotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Hsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2008.s.013_bib1","series-title":"World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue","first-page":"189","author":"Jaffe","year":"2001"},{"key":"10.3816\/CLM.2008.s.013_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib3","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Armitage","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.20307","article-title":"Current views in HTLV-I-associated adult T-cell leukemia\/lymphoma","volume":"78","author":"Nicot","year":"2005","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s10552-008-9147-4","article-title":"Lymphoma survival patterns by WHO subtype in the United States, 1973\u20132003","volume":"19","author":"Han","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.3816\/CLM.2008.s.013_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ni1436","article-title":"Key factors in the organized chaos of early T cell development","volume":"8","author":"Hayday","year":"2007","journal-title":"Nat Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1056\/NEJM200007133430207","article-title":"The immune system. Second of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2008.s.013_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1056\/NEJM200007063430107","article-title":"The immune system. First of two parts","volume":"343","author":"Delves","year":"2000","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2008.s.013_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1600-065X.2006.00478.x","article-title":"Development and selection of gammadelta T cells","volume":"215","author":"Xiong","year":"2007","journal-title":"Immunol Rev"},{"key":"10.3816\/CLM.2008.s.013_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1016-8478(23)10750-3","article-title":"Development of natural killer cells from hematopoietic stem cells","volume":"24","author":"Yoon","year":"2007","journal-title":"Mol Cells"},{"issue":"suppl 1","key":"10.3816\/CLM.2008.s.013_bib11","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1002\/eji.200737593","article-title":"Regulatory T cells -a brief history and perspective","volume":"37","author":"Sakaguchi","year":"2007","journal-title":"Eur J Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib12","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1182\/blood-2004-03-1206","article-title":"Unique gene expression program of human germinal center T helper cells","volume":"104","author":"Kim","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib13","first-page":"359","article-title":"Unraveling the mystery of gammadelta T cell recognizing lipid A","volume":"2","author":"Cui","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cyto.b.20063","article-title":"Flow cytometric immunophenotypic profiles of mature gamma delta T-cell malignancies involving peripheral blood and bone marrow","volume":"67","author":"Ahmad","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"key":"10.3816\/CLM.2008.s.013_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.4049\/jimmunol.176.3.1543","article-title":"Human alpha beta and gamma delta thymocyte development: TCR gene rearrangements, intracellular TCR beta expression, and gamma delta developmental potential\u2013differences between men and mice","volume":"176","author":"Joachims","year":"2006","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.coi.2007.03.001","article-title":"NKT cells: T lymphocytes with innate effector functions","volume":"19","author":"Van Kaer","year":"2007","journal-title":"Curr Opin Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/MO:23:1:17","article-title":"T-cell prolymphocytic leukemia","volume":"23","author":"Dearden","year":"2006","journal-title":"Med Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib18","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.seminoncol.2006.01.015","article-title":"Prolymphocytic leukemias","volume":"33","author":"Krishnan","year":"2006","journal-title":"Semin Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1600-0609.2008.01069.x","article-title":"Prolymphocytic leukaemia of B-and T-cell subtype: a state-of-the-art paper","volume":"80","author":"Dungarwalla","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2008.s.013_bib20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaad.2006.04.060","article-title":"T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism","volume":"55","author":"Magro","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib21","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3816\/CLM.2005.n.051","article-title":"T-cell prolymphocytic leukemia: a single-institution experience","volume":"6","author":"Ravandi","year":"2005","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLM.2008.s.013_bib22","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1182\/blood.V78.12.3269.3269","article-title":"Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia","volume":"78","author":"Matutes","year":"1991","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2007.02.034","article-title":"Skin involvement in T-cell prolymphocytic leukemia","volume":"57","author":"Herling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1309\/93P42RNG5XBG3KBE","article-title":"T-cell prolymphocytic leukemia involving extramedullary sites","volume":"123","author":"Valbuena","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1309\/KWJYBCCGTB90B6AE","article-title":"Mature T-cell leukemias including T-prolymphocytic leukemia, adult T-cell leukemia\/lymphoma, and Sezary syndrome","volume":"127","author":"Foucar","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib26","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2007-07-101519","article-title":"High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia","volume":"111","author":"Herling","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib27","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1038\/sj.leu.2404877","article-title":"Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32)","volume":"21","author":"D\u00fcrig","year":"2007","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2008.s.013_bib28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1023\/A:1008439620513","article-title":"Report of the European Task Force on Lymphomas: workshop on peripheral T-cell lymphomas","volume":"9","author":"Campo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib29","article-title":"Translocations t(X;14)(q28;q11) and t(Y;14)(q12;q11) in T-cell prolymphocytic leukemia","author":"de Oliveira","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nm1097-1155","article-title":"Biallelic mutations in the ATM gene in T-prolymphocytic leukemia","volume":"3","author":"Stilgenbauer","year":"1997","journal-title":"Nat Med"},{"key":"10.3816\/CLM.2008.s.013_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ng0997-96","article-title":"Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia","volume":"17","author":"Vorechovsky","year":"1997","journal-title":"Nat Genet"},{"key":"10.3816\/CLM.2008.s.013_bib32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.10398","article-title":"Indolent T-cell prolymphocytic leukemia: a case report and a review of the literature","volume":"74","author":"Cavazzini","year":"2003","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ajh.10221","article-title":"Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?","volume":"71","author":"Soma","year":"2002","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1634\/theoncologist.9-3-247","article-title":"T-cell large granular lymphocyte leukemia and related disorders","volume":"9","author":"Rose","year":"2004","journal-title":"Oncologist"},{"key":"10.3816\/CLM.2008.s.013_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1634\/theoncologist.11-3-263","article-title":"Large granular lymphocyte leukemia","volume":"11","author":"Sokol","year":"2006","journal-title":"Oncologist"},{"key":"10.3816\/CLM.2008.s.013_bib36","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/107327480701400207","article-title":"Diseases of large granular lymphocytes","volume":"14","author":"Alekshun","year":"2007","journal-title":"Cancer Control"},{"key":"10.3816\/CLM.2008.s.013_bib37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ajh.20853","article-title":"Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature","volume":"82","author":"Alekshun","year":"2007","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib38","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1309\/A8FHDA0VVRJ05GJP","article-title":"T-cell large granular leukemia and related proliferations","volume":"127","author":"O'Malley","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib39","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cncr.22032","article-title":"T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature","volume":"107","author":"Osuji","year":"2006","journal-title":"Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10245330600774793","article-title":"T-large granular lymphocyte leukemia: current molecular concepts","volume":"11","author":"Wlodarski","year":"2006","journal-title":"Hematology"},{"key":"10.3816\/CLM.2008.s.013_bib41","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib42","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.4049\/jimmunol.172.3.1960","article-title":"Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses","volume":"172","author":"O'Keefe","year":"2004","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib43","first-page":"782","article-title":"Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders","volume":"7","author":"Oshimi","year":"1993","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2008.s.013_bib44","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ajh.10480","article-title":"Gammadelta T-cell large granular lymphocyte (LGL) leukemia with spontaneous remission","volume":"75","author":"Shichishima","year":"2004","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.leukres.2007.04.011","article-title":"Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 cases","volume":"32","author":"Bourgault-Rouxel","year":"2008","journal-title":"Leuk Res"},{"key":"10.3816\/CLM.2008.s.013_bib46","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.4161\/cc.5.22.3449","article-title":"Pathophysiology defined by altered signal transduction pathways: the role of JAK-STAT and PI3K signaling in leukemic large granular lymphocytes","volume":"5","author":"Schade","year":"2006","journal-title":"Cell Cycle"},{"key":"10.3816\/CLM.2008.s.013_bib47","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1182\/blood-2004-10-4045","article-title":"Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia","volume":"106","author":"Wlodarski","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib48","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1080\/10428190801932635","article-title":"Chronic B-cell dyscrasias are an important clinical feature of T-LGL leukemia","volume":"49","author":"Viny","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2008.s.013_bib49","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hon.853","article-title":"Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas","volume":"26","author":"Niitsu","year":"2008","journal-title":"Hematol Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib50","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1182\/blood.V97.11.3612","article-title":"Cytogenetic analysis and clinical significance in adult T-cell leukemia\/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki","volume":"97","author":"Itoyama","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib51","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.1038\/sj.onc.1208977","article-title":"Human T-cell leukemia\/lymphoma virus type 1 nonstructural genes and their functions","volume":"24","author":"Nicot","year":"2005","journal-title":"Oncogene"},{"key":"10.3816\/CLM.2008.s.013_bib52","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","article-title":"Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells","volume":"99","author":"Shimauchi","year":"2008","journal-title":"Cancer Sci"},{"key":"10.3816\/CLM.2008.s.013_bib53","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/ijc.22536","article-title":"Regulatory T-cell function of adult T-cell leukemia\/lymphoma cells","volume":"120","author":"Yano","year":"2007","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood-2005-03-1306","article-title":"T-cell non-Hodgkin lymphoma","volume":"107","author":"Rizvi","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/pbc.21543","article-title":"Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study","volume":"51","author":"Hutchison","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib56","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/pbc.21293","article-title":"Peripheral T-cell lymphoma in childhood: population-based experience in the United Kingdom over 20 years","volume":"50","author":"Windsor","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib57","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification","volume":"9","author":"L\u00f3pez-Guillermo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib58","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/1042819021000030054","article-title":"Peripheral T-cell lymphomas: clinical features and prognostic factors of 92 cases defined by the revised European American lymphoma classification","volume":"44","author":"Arrowsmith","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2008.s.013_bib59","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1309\/835B04QXGNNFNRJU","article-title":"Detection of mature T-cell leukemias by flow cytometry using anti-T-cell receptor V beta antibodies","volume":"120","author":"Beck","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2141.2008.07042.x","article-title":"Cytogenetic abnormalities and clinical correlations in peripheral T-cell lymphoma","volume":"141","author":"Nelson","year":"2008","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.s.013_bib61","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI26833","article-title":"Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets","volume":"117","author":"Piccaluga","year":"2007","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2008.s.013_bib62","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/sj.leu.2403960","article-title":"Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas","volume":"19","author":"Martinez-Delgado","year":"2005","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2008.s.013_bib63","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.onc.1209178","article-title":"Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas","volume":"25","author":"Ballester","year":"2006","journal-title":"Oncogene"},{"key":"10.3816\/CLM.2008.s.013_bib64","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","author":"Cuadros","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib65","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/0046-8177(90)90148-X","article-title":"Peripheral T-cell lymphomas: a clinicopathologic study of 75 cases","volume":"21","author":"Chott","year":"1990","journal-title":"Hum Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2008.07352.x","article-title":"Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma","author":"Bacon","year":"2008","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.s.013_bib67","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/MOH.0b013e328186ffbf","article-title":"Angioimmunoblastic T cell lymphoma: pathobiological insights and clinical implications","volume":"14","author":"Dunleavy","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.3816\/CLM.2008.s.013_bib68","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","article-title":"Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials","volume":"111","author":"Mourad","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib69","doi-asserted-by":"crossref","first-page":"10703","DOI":"10.1158\/0008-5472.CAN-07-1708","article-title":"Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation","volume":"67","author":"Piccaluga","year":"2007","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.s.013_bib70","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/labinvest.3700145","article-title":"Vascular endothelial growth factor-A is expressed both on lymphoma cells and endothelial cells in angioimmunoblastic T-cell lymphoma and related to lymphoma progression","volume":"84","author":"Zhao","year":"2004","journal-title":"Lab Invest"},{"key":"10.3816\/CLM.2008.s.013_bib71","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","article-title":"ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project","volume":"111","author":"Savage","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib72","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00428-008-0616-7","article-title":"Morphological variability of lymphohistiocytic variant of anaplastic large cell lymphoma (former lymphohistiocytic lymphoma according to the Kiel classification)","volume":"452","author":"Klapper","year":"2008","journal-title":"Virchows Arch"},{"key":"10.3816\/CLM.2008.s.013_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc2291","article-title":"The anaplastic lymphoma kinase in the pathogenesis of cancer","volume":"8","author":"Chiarle","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib74","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.leu.2401878","article-title":"Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas","volume":"14","author":"Drexler","year":"2000","journal-title":"Leukemia"},{"key":"10.3816\/CLM.2008.s.013_bib75","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1182\/blood.V96.2.398","article-title":"Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas","volume":"96","author":"Wellmann","year":"2000","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib76","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/sj.onc.1210346","article-title":"Oncogenic tyrosine kinase NPM\/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway","volume":"26","author":"Marzec","year":"2007","journal-title":"Oncogene"},{"key":"10.3816\/CLM.2008.s.013_bib77","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1182\/blood-2007-02-071258","article-title":"The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1\/2 and JunB translation via mTOR signaling","volume":"110","author":"Staber","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/nm1659","article-title":"STAT5A is epigenetically silenced by the tyrosine kinase NPM1-ALK and acts as a tumor suppressor by reciprocally inhibiting NPM1-ALK expression","volume":"13","author":"Zhang","year":"2007","journal-title":"Nat Med"},{"key":"10.3816\/CLM.2008.s.013_bib79","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2353\/ajpath.2008.070858","article-title":"CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells","volume":"172","author":"Hirsch","year":"2008","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib80","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1309\/LRKX8CE7GVPCR1FT","article-title":"Hepatosplenic and other gammadelta T-cell lymphomas","volume":"127","author":"Vega","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00000478-200003000-00016","article-title":"Hepatosplenic T-cell lymphoma of alphabeta lineage in a 16-year-old boy presenting with hemolytic anemia and thrombocytopenia","volume":"24","author":"Lai","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib82","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000478-200103000-00002","article-title":"Hepatosplenic alphabeta T-cell lymphomas: a report of 14 cases and comparison with hepatosplenic gammadelta T-cell lymphomas","volume":"25","author":"Macon","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib83","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00000478-200007000-00016","article-title":"Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma","volume":"24","author":"Suarez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib84","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1309\/NW2BK1DXB0EQG55H","article-title":"Enteropathy-type T-cell lymphoma","volume":"127","author":"Zettl","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib85","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1053\/j.gastro.2007.03.036","article-title":"Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes","volume":"132","author":"Deleeuw","year":"2007","journal-title":"Gastroenterology"},{"key":"10.3816\/CLM.2008.s.013_bib86","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/cncr.23316","article-title":"Natural killer cell neoplasms","volume":"112","author":"Liang","year":"2008","journal-title":"Cancer"},{"issue":"1 suppl 1","key":"10.3816\/CLM.2008.s.013_bib87","first-page":"S46","article-title":"Extranodal peripheral T-cell and NK-cell neoplasms","volume":"111","author":"Jaffe","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib88","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1309\/2F39NX1AL3L54WU8","article-title":"NK-cell lymphomas and leukemias: a spectrum of tumors with variable manifestations and immunophenotype","volume":"127","author":"Hasserjian","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib89","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0002-9440(10)64818-3","article-title":"Consistent patterns of allelic loss in natural killer cell lymphoma","volume":"157","author":"Siu","year":"2000","journal-title":"Am J Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib90","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2141.1999.01410.x","article-title":"Chromosome aberrations are restricted to the CD56+, CD3-tumour cell population in natural killer cell lymphomas: a combined immunophenotyping and FISH study","volume":"105","author":"Zhang","year":"1999","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.s.013_bib91","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects","volume":"32","author":"Burg","year":"2005","journal-title":"J Cutan Pathol"},{"key":"10.3816\/CLM.2008.s.013_bib92","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib93","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0190-9622(90)70074-R","article-title":"Cutaneous T cell lymphoma with suppressor\/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes","volume":"22","author":"Agnarsson","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib95","first-page":"628","article-title":"CD8+ cutaneous T-cell lymphoma","volume":"13","author":"Agnarsson","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.3816\/CLM.2008.s.013_bib96","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jaad.2005.06.044","article-title":"Rapid onset of CD8+ aggressive T-cell lymphoma during bexarotene therapy in a patient with Sezary syndrome","volume":"53","author":"Kreuter","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib97","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000087025","article-title":"Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement","volume":"211","author":"Marzano","year":"2005","journal-title":"Dermatology"},{"key":"10.3816\/CLM.2008.s.013_bib98","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/cncr.11107","article-title":"Cytotoxic\/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop","volume":"97","author":"Santucci","year":"2003","journal-title":"Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":"Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.3816\/CLM.2008.s.013_bib100","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib101","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1046\/j.1365-2141.2003.04359.x","article-title":"Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions","volume":"121","author":"Zhang","year":"2003","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2008.s.013_bib102","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1200\/JCO.2000.18.15.2908","article-title":"Primary cutaneous T-cell lymphoma: review and current concepts","volume":"18","author":"Siegel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib103","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/gcc.10152","article-title":"Molecular cytogenetic characterization of Sezary syndrome","volume":"36","author":"Mao","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib104","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1046\/j.1365-2133.2002.04966.x","article-title":"Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in S\u00e9zary syndrome and mycosis fungoides","volume":"147","author":"Mao","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib105","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V100.9.3369","article-title":"Clonal heterogeneity in mycosis fungoides and its relationship to clinical course","volume":"100","author":"Vega","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib106","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.176.7.4431","article-title":"The vast majority of CLA+ T cells are resident in normal skin","volume":"176","author":"Clark","year":"2006","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2008.s.013_bib107","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.3816\/CLM.2008.s.013_bib108","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/ijc.20922","article-title":"CCR10 is expressed in cutaneous T-cell lymphoma","volume":"115","author":"Notohamiprodjo","year":"2005","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2008.s.013_bib109","first-page":"2682","article-title":"Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?","volume":"7","author":"Ni","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2008.s.013_bib110","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib111","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1158\/1078-0432.CCR-04-2514","article-title":"Decreased T-cell receptor excision circles in cutaneous T-cell lymphoma","volume":"11","author":"Yamanaka","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2008.s.013_bib112","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1182\/blood-2003-04-1044","article-title":"Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma","volume":"102","author":"Yawalkar","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib113","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1182\/blood-2005-03-1139","article-title":"Skin-derived interleukin-7 contributes to the proliferation of lymphocytes in cutaneous T-cell lymphoma","volume":"107","author":"Yamanaka","year":"2006","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib114","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jnci\/82.3.208","article-title":"Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kaplan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2008.s.013_bib116","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2008.s.013_bib117","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1182\/blood.V98.9.2865","article-title":"Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report","volume":"98","author":"Piekarz","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib118","first-page":"718","article-title":"Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms","volume":"8","author":"Sandor","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLM.2008.s.013_bib119","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1158\/0008-5472.CAN-07-6091","article-title":"Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma","volume":"68","author":"Fantin","year":"2008","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2008.s.013_bib120","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0190-9622(90)70054-L","article-title":"S\u00e9zary syndrome: diagnosis, prognosis, and critical review of treatment options","volume":"22","author":"Wieselthier","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib121","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib122","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib123","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/j.1365-2133.2008.08566.x","article-title":"MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"158","author":"Kempf","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2008.s.013_bib124","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJM198608213150802","article-title":"Clonal T-cell populations in lymphomatoid papulosis. Evidence of a lymphoproliferative origin for a clinically benign disease","volume":"315","author":"Weiss","year":"1986","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2008.s.013_bib125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0923-1811(93)90001-6","article-title":"Molecular evidence for a clonal relationship between lymphomatoid papulosis and Ki-1 positive large cell anaplastic lymphoma","volume":"6","author":"Volkenandt","year":"1993","journal-title":"J Dermatol Sci"},{"key":"10.3816\/CLM.2008.s.013_bib126","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone","volume":"326","author":"Davis","year":"1992","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2008.s.013_bib127","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1182\/blood-2003-03-0899","article-title":"Bone marrow precursor of extranodal T-cell lymphoma","volume":"102","author":"Gniadecki","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2008.s.013_bib128","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0002-9440(10)64073-4","article-title":"Comparative genome-scale analysis of gene expression profiles in T cell lymphoma cells during malignant progression using a complementary DNA microarray","volume":"158","author":"Li","year":"2001","journal-title":"Am J Pathol"},{"issue":"suppl 1","key":"10.3816\/CLM.2008.s.013_bib129","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0303-6987.2006.00507.x","article-title":"Pathobiology of CD30+ cutaneous T-cell lymphomas","volume":"33","author":"Kadin","year":"2006","journal-title":"J Cutan Pathol"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011702761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T02:37:15Z","timestamp":1709779035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011702761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":129,"alternative-id":["S1557919011702761"],"URL":"https:\/\/doi.org\/10.3816\/clm.2008.s.013","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}